Clinical Trial Update: Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

View source ↗

Summary

This clinical trial assesses whether minimal residual disease can predict therapeutic efficacy in metastatic hormone-sensitive prostate cancer; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Anhui Medical University | Conditions: MRD, Prostate Cancer | Status: NOT_YET_RECRUITING